OncLive | Bringing the Global Oncology Community Together

Transplant-associated thrombotic microangiopathy occurred in as many as 36% of hematopoietic cell transplants and significantly increased the risk of transplant-related mortality. Read More >>

Expert Highlights Nivolumab/Ipilimumab Potential in mCRPC

TCT 2019: Locke Covers AE Management Linked With CAR T-Cell Therapies

CLL Research Explores Feasibility of Time-Limited Treatment

Real-World Ibrutinib Survival Data in MCL Consistent With Clinical Trials

SM-88 Safe, Active in Nonmetastatic CRPC

View More Stories >>

View Conference Coverage

2019 Genitourinary Cancers Symposium

2019 Transplantation and Cellular Therapy Meetings

2019 Winter Lung Cancer Conference

2019 SGO Winter Meeting

2019 Gastrointestinal Cancers Symposium

Dr. Subramanian Discusses Tumor Biology in Lung Cancer

Dr. Yu Discusses Treatment Strategies for Patients With Oligometastatic Prostate Cancer

Dr. Chung on the COMPASS Trial in Pancreatic Cancer

Dr. Champlin on the Role of EASIX Following Allogeneic Stem Cell Transplant

OncLive houses thousands of videos that provide updates and information.
See more Videos

Sequencing Therapy in CRC: E7208 Trial

Maintenance Strategies for Patients With mCRC

The Evolving Role of Transplant in ALL

Cause for Optimism in Follicular Lymphoma Treatment

$Proteasome Inhibitors in Relapsed-Refractory Myeloma$

OncLive houses thousands of videos that provide updates and information.
See more Videos

High-Risk Smoldering Multiple Myeloma: Systemic Therapy

Smoldering Multiple Myeloma Treatment Considerations

MCL: Novel BTK Inhibitor Combination Strategies

$Identifying Unmet Needs in Relapsed/Refractory MCL$

Multidisciplinary Management: Selecting a Therapy

The Role of Neoadjuvant Therapy in Pancreatic Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>